Metropolis Healthcare Limited Stock Beta
| METROPOLIS | 2,062 46.70 2.32% |
Metropolis Healthcare Limited fundamentals help investors to digest information that contributes to Metropolis Healthcare's financial success or failures. It also enables traders to predict the movement of Metropolis Stock. The fundamental analysis module provides a way to measure Metropolis Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Metropolis Healthcare stock.
Metropolis | Beta |
Metropolis Healthcare Limited Company Beta Analysis
Metropolis Healthcare's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Metropolis Healthcare Beta | 0.34 |
Most of Metropolis Healthcare's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Metropolis Healthcare Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Metropolis Healthcare Limited has a Beta of 0.341. This is 60.35% lower than that of the Biotechnology sector and 76.32% lower than that of the Health Care industry. The beta for all India stocks is notably lower than that of the firm.
Metropolis Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Metropolis Healthcare's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Metropolis Healthcare could also be used in its relative valuation, which is a method of valuing Metropolis Healthcare by comparing valuation metrics of similar companies.Metropolis Healthcare is currently under evaluation in beta category among its peers.
As returns on the market increase, Metropolis Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Metropolis Healthcare is expected to be smaller as well.
Metropolis Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0863 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 103.35 B | ||||
| Shares Outstanding | 51.27 M | ||||
| Shares Owned By Insiders | 44.41 % | ||||
| Shares Owned By Institutions | 45.34 % | ||||
| Price To Book | 8.73 X | ||||
| Price To Sales | 8.07 X | ||||
| Revenue | 12.08 B | ||||
| Gross Profit | 9.1 B | ||||
| EBITDA | 2.97 B | ||||
| Net Income | 1.28 B | ||||
| Cash And Equivalents | 198.82 M | ||||
| Total Debt | 1.97 B | ||||
| Book Value Per Share | 231.09 X | ||||
| Cash Flow From Operations | 2.64 B | ||||
| Earnings Per Share | 28.69 X | ||||
| Target Price | 2152.41 | ||||
| Number Of Employees | 4.31 K | ||||
| Beta | 0.34 | ||||
| Market Capitalization | 103.71 B | ||||
| Total Asset | 15.55 B | ||||
| Retained Earnings | 9.17 B | ||||
| Working Capital | 699.55 M | ||||
| Net Asset | 15.55 B |
About Metropolis Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Metropolis Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Metropolis Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Metropolis Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Metropolis Stock
Metropolis Healthcare financial ratios help investors to determine whether Metropolis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Metropolis with respect to the benefits of owning Metropolis Healthcare security.